Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Cash (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Change in Cash readings, the most recent being $374.0 million for Q4 2025.

  • Quarterly Change in Cash rose 444.12% to $374.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $363.3 million through Dec 2025, up 345.71% year-over-year, with the annual reading at $363.3 million for FY2025, 345.71% up from the prior year.
  • Change in Cash hit $374.0 million in Q4 2025 for Terns Pharmaceuticals, up from $4.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $374.0 million in Q4 2025 and bottomed at -$108.7 million in Q4 2024.
  • Average Change in Cash over 5 years is $22.5 million, with a median of $947000.0 recorded in 2021.
  • Peak annual rise in Change in Cash hit 3899.52% in 2021, while the deepest fall reached 495.74% in 2021.
  • Terns Pharmaceuticals' Change in Cash stood at -$17.1 million in 2021, then surged by 570.67% to $80.3 million in 2022, then crashed by 47.63% to $42.0 million in 2023, then plummeted by 358.6% to -$108.7 million in 2024, then skyrocketed by 444.12% to $374.0 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Change in Cash are $374.0 million (Q4 2025), $4.7 million (Q3 2025), and $6.9 million (Q2 2025).